BLAINTRAMUSCULARSUSPENSION
Approved
May 2024
Lifecycle
Growth
Competitive Pressure
30/100
Clinical Trials
15
Data completeness
2/8 — Basic
Drug data last refreshed 15h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
mRESVIA is an mRNA-based respiratory syncytial virus (RSV) vaccine approved by the FDA on May 31, 2024, designed to prevent RSV infection via intramuscular injection. The vaccine leverages Moderna's mRNA platform to stimulate immune response against RSV, a significant respiratory pathogen affecting vulnerable populations. It represents a new preventive option in the growing RSV vaccine market.
Growth
Early-stage growth product with 185 linked positions indicates expanding teams across manufacturing, engineering, and regulatory functions as commercial scale-up accelerates.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (15)
A Study to Evaluate the Immune Response Features Following Vaccination With a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)
Started Jun 2026
60 enrolled
Respiratory Syncytial Virus (RSV)
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Started Oct 2025
25,000 enrolled
Respiratory Syncytial Virus (RSV)
A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Started Nov 2024
42 enrolled
RSV ImmunisationHealthy Volunteers
Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Started May 2024
2,226 enrolled
RSV Immunization
Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Started Feb 2024
6,300 enrolled
RSV Immunisation
Worked on mRESVIA at Moderna? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.